Government’s new drug pricing policy to meet backlash

Published: 2008-05-30 06:54:00

Updated: 2008-05-30 06:54:00

After the Health Insurance Review Agency unveiled its assessment results of lipid-lowering agents last week, the agency is likely to meet backlash from the domestic pharmaceutical industry.

The nation’s two business lobby groups – Korea Pharmaceutical Manufacturers Association and Korea Resear...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK